Deep Med IO Company

DeepMed IO's mission is to use AI to increase the speed of diagnostic tasks and accuracy of diagnostic processes, deliver personalized care solutions for patients, thus prolonging their survival and improving their quality of life. The company's software facilitates and augments expert pathologists by employing artificial intelligence technology to pre-annotate and analyze WSI slides, ready to be validated by the experts. The deep-learning neural networks are specifically trained for each module of streamlined workflow, utilizing expert-curated training sets and validated by quality-assured datasets.
Technology: Machine Learning
Industry: AI for Longevity
Headquarters: Manchester, Manchester, United Kingdom
Founded Date: 2017
Employees Number: 11-50
Funding Status: Grant
Investors Number: 2
Total Funding: £1 264 723
Estimated Revenue: < £780 000
Last Funding Date: 5/3/2019
Last Funding Type: N/A

Visit Website
Register and Claim Ownership